NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
73 hedge funds and large institutions have $403M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 4 closing their positions.
Holders
73
Holders Change
+14
Holders Change %
+23.73%
% of All Funds
1.61%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
18
Increased
25
Reduced
16
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Nuveen Asset Management
Chicago,
Illinois
|
$1.41M |
| 2 |
OAM
2
Oxford Asset Management
Oxford,
United Kingdom
|
$0 |
| 3 |
3
BlackRock
New York
|
$27.8M |
| 4 |
4
Morgan Stanley
New York
|
$35K |
| 5 |
5
Goldman Sachs
New York
|
$549K |
